docetaxel

March 15, 2016March 16, 2016

For Previously Treated Non-Small-Cell Lung Cancer, Atezolizumab Seems to Be More Effective than Docetaxel, Report Shows

Lung Cancer, News

A recent Phase 2 clinical trial demonstrated that the cancer treatment atezolizumab was more effective compared to docetaxel at improving survival in patients with previously treated non-small-cell lung cancer (NSCLC). The research ... Read more

October 29, 2015October 29, 2015

Merck’s NSCLC Drug Keytruda Outperforms Established Chemotherapy Drug

Lung Cancer, News

Merck recently announced topline data from the KEYNOTE-010 clinical trial assessing pembrolizumab as a treatment for patients with advanced non-small-cell lung cancer (NSCLC), determining that the study met its initial endpoint. Pembrolizumab (formerly MK-3475 and lambrolizumab, ... Read more

October 22, 2015October 22, 2015

Synta Ceases Phase 3 GALAXY-2 Trial in Patients with Advanced Non-small Cell Lung Adenocarcinoma

Lung Cancer, News

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on research, development and commercialization of novel oncology medicines, recently announced that the company has decided to cease its Phase 3 GALAXY-2 trial of docetaxel ... Read more

June 2, 2015June 2, 2015

Opdivo (Nivolumab) Treatment Found to Offer Higher Overall Survival in Patients With Non-Small Cell Lung Cancer

Lung Cancer, News

Promising data on a Phase III trial (NCT01673867) to assess the safety and efficacy of nivolumab in the treatment of non-squamous non-small cell lung cancer (NSCLC) was recently presented at ... Read more